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The Properties of An Immature Glial Cell Line (HITS Glioma) Derived 
from Ethylnitrosourea (ENU)-Induced Rat Glioma
Yuji Ikeno
The First Department of Pathology, Nagasaki University School of Medicine, 1-12-4 Sakamoto, Nagasaki 852, Japan
In order to evaluate the proliferation and differentiation potentials of 
ethylnitrosourea (ENU)-induced glioma cells, the author attempted to 
obtain a cell line that maintains glial features in long term culture. 
One of five cell lines cultivated from ENU-induced rat gliomas 
deserved particular interest because of the differentiation of the 
neoplastic glia. This cell line, designated as HITS glioma, had a 
polygonal cell body and formed a monolayer with pile-up foci in vitro, 
in contrast to the other cell lines, which showed a mesenchymal drift 
through passages. GFAP-positive cells, found in the primary culture, 
disappeared in the late passages of HITS glioma as they did in the 
other cell lines. Galactocerebroside (GC) and GD3 ganglioside were 
not expressed in the cell lines during culture. Subcutaneous 
inoculation of HITS glioma into neonatal rats induced tumors with 
various histopathological components mimicking the histopathological 
appearance of ENU-induced gliomas. The components also had a 
fraction of GFAP-positive cells. These findings indicate that HITS 
glioma cells may be composed of immature glial cells and differentiate 
into astrocytic cells under certain conditions. Insulin-like growth 
factor I (IGF-I), which promoted the proliferation of GFAP-positive 
cells in neonatal glia, was used to evaluate the mechanism(s) of 
proliferation and/or differentiation of HITS glioma. IGF-I did not 
induce the expression of GFAP in HITS glioma, even though it 
promoted the proliferation of HITS glioma. Although the mechanism 
involving the astrocytic differentiation of HITS glioma is unknown, 
HITS glioma may serve as a research tool in evaluating the 
mechanisms of proliferation and differentiation of neoplastic glia.
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Introduction 
Ethylnitrosourea(ENU)-induced gliomas in the rats' are 
histopathologically similar to oligodendroglioma, mixed 
oligo-astrocytoma, astrocytoma, and anaplastic glioma in 
humans,"' and have been utilized extensively as an exper-
imental model of human gliomas. Many investigators have
Corresponding Author: Name: Yuji Ikeno 
Mailing Address: The First Department of Pathology, 
Nagasaki University School of Medicine, 1-12-4 
Sakamoto, Nagasaki 852, Japan 
Phone: 0958-47-2111 Ext. 2192 
FAX: 0958-47-8514
been intrigued by the polymorphic phenotype of this tumor 
model, which may indicate the existence of pluripotent 
neoplastic glia and provide a way to investigate the differ-
entiation of normal as well as neoplastic glia. However, 
there is still some controversy about this model. Reactive 
astrocytes, which appear within and around gliomas during 
the neoplastic process, complicated in vivo studies. Mauro 
et al."' and Shimokawa' indicated that most, if not all, 
GFAP-positive cells within tumors could be reactive cells, 
while other investigators29'37.38> considered them neoplastic 
cells. In our laboratory, Higami suggested the reactive 
nature of GFAP-positive cells in the glioma using primary 
culture cells. 121 However, the possibility remained that 
GFAP-negative neoplastic glia differentiate into astrocytic 
cells under certain conditions. A cell line, derived from 
ENU-induced glioma, has expressed GFAP in a fraction of 
cells.") The author have also cultured a cell line which 
expressed GFAP, not in vitro but only in transplanted sites 
of neonatal rats. In this report, the author take up the task 
of characterizing this cell line, designated as HITS glioma. 
  Recent advances in oncology have revealed the signif-
icant role of growth factors or oncogenes in the devel-
opment of neoplasms.31.32) Insulin-like growth factor I 
(IGF-I), which is increased in the serum of animals at the 
onset of puberty,"' regulates the proliferation and differen-
tiation of normal and neoplastic glia.22.23,2A3o, The response 
of HITS glioma to IGF-I was examined to elucidate the 
mechanism(s) of cell proliferation and GFAP-expression in 
cells after transplantation.
Materials and Methods 
Experimental Animals and Tumor Induction 
Glioma induction was conducted according to the method 
of Koestner et al."' Briefly, pregnant Wistar rats on the 
15th day of gestation received an intravenous injection of a 
single 50mg/kg body weight dose of N-ethyl-N-nitrosourea 
(ENU, Nakarai Chemical, Ltd., Kyoto, Japan) dissolved in 
distilled water. After delivery, the offspring were fed ad 
libitum for 6-9 months and sacrificed under ether anes-
thesia when neurological symptoms appeared. Neonatal 
rats were used as controls and sacrificed on the day of 
birth. 
Cell Culture 
A half portion of macroscopic glioma or the cerebral 
hemisphere of neonatal rats was minced and digested with 
0.25% trypsin (GIBCO, U.S.A.) at 37 °C for 15min. Iso-
lated cells were suspended in Eagle's Minimum Essential 
Medium (MEM, GIBCO) supplemented with 10% fetal 
bovine serum (FBS, GIBCO) and antibiotics (10 units/ml 
penicillin G sodium, 10 ,ug/ml streptomycin sulfate, 0.025 
,ug/ml amphotericin B, GIBCO), and incubated at 37 °C in 
55cm2 petri dishes in a 5% humidified atmosphere. In the 
glioma-derived cell cultures, passages were performed 
when the culture dishes became confluent. Cells were 
washed with Ca++ Mg++-free phosphate buffered saline 
(CMF-PBS), detached from the dishes with 0.05% tryp-
sin/0.02% EDTA-PBS solution and inoculated into new 
culture dishes. The splitting ratio was 1:4. At the same 
time, a portion of the subcultivated cells was inoculated 
onto a cover slip sheeted into new dishes and grown for a 
day for immunocytochemical examination. 
Subcutaneous Inoculation of Cultured Cells 
HITS glioma and one other cell line (RT1005)-l x 106 cells 
in 0.5ml phosphate buffered saline (PBS)-were subcuta-
neously inoculated into 1-day-old neonatal rats. The tumors 
were harvested at a 3.0-4.0cm diameter. Each tumor was 
dissected free of connective tissue, fixed, and processed for 
hematoxylin-eosin and immunohistochemical examination. 
Tissue Preparation for Histological and Immunohis-
tochemical Examination 
A portion of the original gliomas and transplanted tumors 
was fixed in 4% paraformaldehyde/0.1M PB at 4 °C over-
night. After fixation, the specimens were dehydrated, em-
bedded in paraffin and cut into 5 gm thick serial sections. 
Another portion of the specimens was cut in 2mm thick 
slices, placed in 0. C. T. compound (Miles, U.S.A.) and 
quickly frozen in ethanol cooled by dry ice to -80 °C . The 
specimens were cut into 5 ,um sections on a cryostat and 
fixed for 10min. with cold acetone. The serial sections 
were mounted on glass slides coated with poly-L-lysine 
(Sigma, Deisenhofen, FRG), and stained with hematoxylin-
eosin or used for immunohistochemical examination. 
Immunostaining 
The primary antibodies used in this study and their optimal 
dilutions were as follows: Rabbit anti-cow GFAP (glial 
fibrillary acidic protein, 1:800, DAKO, Denmark), Rabbit
anti-bovine galactocerebroside (1:200, Chemicon Interna-
tional, Inc., California, U.S.A.), Rabbit anti-human MBP 
(Myelin basic protein, 1:200, DAKO), Mouse anti-GD3 
ganglioside (1:1600, Dr. A. Houghton, Sloan Kettering 
Memorial Institute, New York, U.S.A.). Galactocerebroside 
(GC) was used as an oligodendrocytic marker in vitro for 
frozen sections, since MBP displayed a frequent non-
specific staining in culture cells. The avidin-biotin perox-
idase complex (ABC) method 13, was applied to demonstrate 
GFAP, MBP, GC and GD3 on tissue specimens and cul-
tured cells. Commercial reagents were used (VECTAS-
TAIN, VECTOR LABORATORIES, California, -U.S.A.). 
Negative controls included replacement of the primary 
antibodies with normal rabbit serum (1:200-1600, DAKO). 
The immunoreactivity to rat positive control specimen of 
these primary antibodies was determined before use. 
  In the immunocytochemical analysis, GFAP-, GC-, and 
GD3- positive rates were calculated by counting more than 
500 cells on a cover slip. 
Bromodeoxyulidine (BrdU) Incorporation and Immuno-
staining 
BrdU incorporation was performed to examine the prolif-
erative activity of cultured cells," using an Amersham cell 
proliferation kit (Amersham, England). Culture cells grown 
on. cover slips were incubated with the labelling medium 
containing BrdU (5-bromo-2'-deoxyuridine, BrdU;1:1000 
dilution ratio) for 1 hour, and fixed in 4% parafor-
maldehyde for 20min. The indirect method was used for 
immunocytochemical visualization of BrdU incorporated 
cells. Cells were counterstained with hematoxylin. All steps 
were performed at room temperature. The BrdU incorpo-
ration rates were calculated by counting more than 500 
cells on a cover slip. 
Response of HITS Cells to Insulin-Like Growth Factor-I 
(IGF-I) in vitro 
To elucidate mechanisms of cell proliferation and differen-
tiation, the response to IGF-I was assessed by measuring 
the increased cell number, BrdU incorporation and GFAP-, 
GC-, GD3-expression in HITS glioma in vitro. To measure 
the increased cell number, 2 x 104 cells were inoculated in 
21 cm' culture dishes with MEM + 10% FBS. The following 
day, the culture medium was replaced by the following 
culture mediums; (a) MEM + 10% FBS, (b) MEM + 0.1 % 
FBS + Insulin-like growth factor-I (IGF-I, Collaborative 
Research, Inc., U. S. A.) in 10, 100, 200ng/ml amounts, (C) 
MEM + 0.1 % FBS. Each culture medium was replaced by 
fresh medium on the 4th day, and the cells were harvested 
on the 7th day and counted using a hemocytometer. 
 To measure the effect of IGF-I on BrdU incorporation 
and GFAP-, GC-, GD3-expression, 5 x 103 cells inoculated 
onto a cover slip were cultivated under the same condi-
tions. These cells were cultured for 12 hours in the exper-
imental media. BrdU incorporation was performed for the 
last 1 hour of the culture, as previously described, and 
immunostaining was also performed. GFAP-, GC- and 
GD3-expression were observed on the 7th day of culture in 
the experimental media. The data were estimated by t-test 
(P < 0.05). 
Transmission Electron Microscopic Examination 
For transmission electron microscopy, the cells were fixed 
with 2.5% glutalaldehyde and postfixed with 1% osmium 
tetroxide in situ. Fixed cells were dehydrated, embedded in 
Epon-Araldite resin, sectioned with an ultramicrotome and 
observed with a JEM-1200EX (JEOL) transmission elec-
tron microscope.
Fig. 1. Lightmicroscopy of an ENU-induced rat glioma. The 
tumor cells show slight pleomorphism and a typical honeycomb 
pattern. (H & E, x 400).
Results 
Original Gliomas 
The five ENU-induced gliomas, from which cell lines in 
this study were derived, were basically oligodendrogliomas 
(Fig. 1). One contained a sarcomatous focus. Astrocytic 
(GFAP-positive) cells were scattered in and around the 
tumors (Fig. 2). Neither GFAP, GC nor MBP was detected 
in the oligodendroglioma cells. 
Culture Cells 
During passages, four of five cell lines showed mesen-
chymal drift developing spindle-shaped cells and losing 
glial features, morphologically. However, the HITS glioma 
possessed a polygonal cell body and a relatively small 
nucleus (Fig. 3), grew in a monolayer and formed pile-up 
foci after 30 days of cultule (6th passage, Fig. 3). HITS 
glioma have been continuously cultivated for more than 
300 days (over 50 passages) and still maintain these fea-
tures. 
 Fig. 4 shows changes in the proportion of GFAP-
positive, BrdU-incorporated cells in each cell line. Al-
though approximately 10% of cultured cells expressed 
GFAP in the early passage of each cell line, the GFAP-
positive cells decreased in proportion and finally disap-
peared. The proportion of BrdU-incorporated cells was 
within the range of approximately 10-15% in each cell line. 
There were no positive cells for GC and GD3 in any of the 
cell lines. 
Subcutaneous Inoculation of HITS Glioma and RT1005 
Cells 
Subcutaneous inoculation of each cell line yielded tumors 
in all recipient rats. These tumors reached diameters of
Fig. 2. Light microscopy of an ENU-induced rat glioma GFAP 
positive cells are located within and around the tumor. (GFAP, x 
600).
Fig. 3. Cultured cells obtained from an ENU-induced rat glioma 
(HITS glioma) showing pile-up focus. (phase contrast x 400)
Fig. 4. The proportion of GFAP-positive, BrdU-incorporated 
cells in each cell line. Although approximately 10% of cultured 
cells expressed GFAP in the early passage of each cell line, the 
GFAP-positive cells decreased in proportion and finally disap-
peared.
3-4cm, 2-8 weeks after inoculation. They were solid, white 
colored, soft tumors with gelatinous appearance and cystic 
change (Fig. 5). The tumors derived from HITS glioma 
consisted of oligodendroglioma (Fig. 6a) and anaplastic 
glioma (Fig. 6b). The tumors also contained a variety of 
minor components including sarcomatous (Fig. 6C), epen-
dymomatous (Fig. 6d), astrocytoma-like foci (Fig. 6e), and 
perivascular proliferation (Fig. 6f). Immunostaining re-
vealed GFAP-positive cells in all areas despite differing 
histopathology (Fig. 7 a-f), although no isomorphic prolif-
eration of GFAP-positive cells was observed. MBP, GC 
and GD3 were not detected in any area of these tumors. 
 Subcutaneous tumors derived from RT1005 cells 
showed only a sarcomatous appearance (Fig. 8). No GFAP-
or MBP- positive cells were found. 
Response of HITS Glioma to IGF-I in vitro 
(1) Cell Proliferation: Cell Number 
The effect of IGF-I (10, 100 and 200 ng/ml) on the prolif-
eration of HITS glioma is shown in Tables 1 and 2. In the 
medium supplemented with 0.1% FBS, IGF-I induced a 
significant increase in the cell number of both neoplastic 
and neonatal glia, compared with controls (0.1 % FBS 
alone). 
(2) Cell Proliferation: BrdU Incorporation 
The effect of IGF-I (10, 100 and 200ng/ml) on BrdU 
incorporation by the cultured tumor cells is shown in Table 
2. In 0.1% FBS supplemented medium, IGF-I induced 
BrdU incorporation of both neoplastic and neonatal glia, 
compared with controls (0.1% FBS alone). IGF-I stimu-
lated BrdU incorporation in a dose-dependent fashion in 
both neonatal and neoplastic glial cultures.
Fig. 5. Transplanted tumor of HITS glioma. The tumor was solid, 
white colored with gelatinous appearance. Cystic change was also 
noted in the tumor.
Effect of IGF-I on the Expression of GFAP, GC and GD3 
IGF-I did not induce antigenic expression of GFAP in 
HITS glioma, although IGF-I increased the proportion and 
absolute cell number of GFAP-positive cells in neonatal 
glial cell culture, depending on the concentration (Table 3). 
IGF-I did not induce antigenic expression of GC or GD3 in 
neoplastic glia nor increase the population of GC or GD3 
positive cells in neonatal glial cell culture. 
Transmission Electron Microscope Examination (Fig. 9) 
Each cell of HITS glioma contained a slightly irregular 
nucleus and a moderate amount of cytoplasm. The nucleus 
contained nucleoli and dense chromatin which were par-
tially attached to the nuclear envelope. A moderate number 
of rER, mitochondria, abundant free ribosomes, and micro-
tubules were observed in the cytoplasm (inset). There were 
thin cytoplasmic processes, but glial filaments were absent.
   Fig. 6 (a-f). Light microscopy of transplanted tumors (HITS glioma). (H & E, x 400) 
6a; Isomorphic proliferation of small round cells corresponding to oligodendroglioma. 
6b; anaplastic glioma-like lesion composed of small polygonal cells. 
6c; sarcomatous focus composed of spindle cells. 
6d; ependymomatous focus composed of small polygonal cells and wide intercellular spaces. 
6e; astrocytoma-like lesion composed of multipolar cells. 
6f; perivascular proliferation composed of spindle cell proliferation in concentric circles.
Fig. 7 (a-f). GFAP immunostaining of transplanted tumors (HITS glioma). (GFAP) 
              7a; oligodendroglioma-like lesion. (x 400) 
              7b; anaplastic glioma-like lesion. (x 600) 
                7c; sarcomatous focus. (x 600) 
              7d; ependymomatous focus. (x 400) 
              7e; astrocytoma-like lesion. (x 400)
              7f; perivascular proliferation. (x 600)
Fig. 8. Light microscopy of another transplanted tumor 
(RT1005) (H & E, x 200) 
The tumor composed of spindle cells lacks the morphological 
feature of primary glioma, histologically.
Fig. 9. Transmission electron micrographs of HITS glioma 
culture. (x 4000) 
Each cell contained a slightly irregular nucleus and a moderate 
amount of cytoplasm. Microtubules were observed in the cyto-
plasm (inset).
Table 1. Effect of IGF-I on the Proliferation of HITS Glioma Cells and Neonatal Rat Glial Cell Culture (x 10'): Cell Number After One 
Week
                                IGF1 (-) lOnglGFl 100ngIGFI 200ngIGF1 
 0.1 %FBS HITS glioma 8.40 ± 0.72 10.33 ± 1.04 16.77 ± 1.65 16.50 ± 0.73                  control glia 2.30 ± 0.21 2.70 ± 0.21 5.07 ± 0.31 5.40 ± 0.38 
 10%FBS HITS glioma 19.23 ± 0.45 -                 control glia 8.07 ± 0.48 -
seeded cell number (approximately 2.0 x 10') 
mean ± standard deviation (n = 3, P < 0.05)
Table 2. Effect of IGF-I on BrdU Incorporation of HITS Glioma Cells and Neonatal Rat Glial Cell Culture (%)
                                IGFI (-) lOngIGF1 IOOngIGFI 200ngIGFI 
 0.1 %FBS HITS glioma 6.40 ± 0.50 9.00 ± 0.28 9.93 ± 0.21 10.30 ± 0.21                  control glia 5.43 ± 0.12 6.33 ± 0.26 8.66 ± 0.35 9.60 ± 0.64
 10%FBS HITS glioma 11.70 ± 0.29 - - -                 control glia 11.00 ± 0.33 - -
seeded cell number (approximately 5.0 x 10) 
mean ± standard deviation (n = 3, P < 0.05)
Table 3. Proportion and Cell Number of GFAP Positive Cells of HITS Glioma Cells and Neonatal Rat Glial Cell Culture
                                   proportion of GFAP positive cells (%) (cell number of GFAP positive cells x10') 
                               IGF1 (-) lOngIGFI 100ngIGF1 200ngIGFI 
 0.1 %FBS HITS glioma 0 0 0 0 
                control glia 19.17 ± 0.76 (0.4) 28.83 ± 1.04 (0.7) 45.50 ± 1.68 (2.3) 48.30 ± 1.02(2.6)
 10%FBS HITS glioma 0 - - -
                control glia 51.60 ± 1.51 (4.1) -
seeded cell number (approximately 5.0 x 10) 
mean ± standard deviation (n = 3, P < 0.05)
Discussion 
Several types of neoplastic glia histologically similar to 
their normal counterparts (oligodendrocytes, astrocytes, 
and immature glia) have been recognized in ENU-induced 
gliomas.17' This fact may indicate the existence of pluri-
potent neoplastic glia. Identification of these pluripotent 
neoplastic glia and the elucidation of the mechanisms of 
their differentiation should therefore promote our under-
standing of their neurobiology. In vivo studies, however, 
have limitations in assigning pluripotent or immature glia to 
specific lineages, and are also complicated by reactive glia. 
In vitro studies circumvent these limitations, although 
antigenic instability or phenotypic change such as mesen-
chymal drift are often observed.",") In order to characterize 
the tumor cells in vitro, it is necessary to obtain cell lines 
which display morphological characteristics similar to the 
tumor cells in vivo. 
  In the present study, four out of five cell lines derived 
from ENU-induced gliomas showed mesenchymal drift, i. 
e. isomorphic proliferation of spindle-shaped cells in late 
passage, but one cell line, the HITS glioma, retained the 
morphological characteristics of cells in the primary culture 
for more than 300 days (over 50 passages) and showed the 
feature of neoplastic oligodendrocyte by electron micros-
copy.") Furthermore, the HITS glioma have shown unique 
characteristics after subcutaneous inoculation into neonatal 
rats, yielding tumors similar to in vivo tumors of several 
histological types, including oligodendroglioma-like le-
sions, anaplastic glioma-like lesions, sarcomatous foci, 
ependymomatous foci, and astrocytoma-like lesions. There 
were apparent transitions among the various components. 
A fraction of the cells expressed GFAP, a specific astrocyte 
marker, and GFAP-positive cells in inoculated tumors 
varied in morphological features, consisting of oligoden-
drocytic, astrocytic and fibroblastic types. These GFAP-
positive cells were negative for MBP, and so the author 
consider that the cells derived from inoculated culture cells 
rather than Schwann cells that migrated from the peripheral 
nerve of recipient rats. Since HITS glioma did not express 
GFAP in vitro, these GFAP-positive cells seemed to origi-
nate from GFAP-negative neoplastic glia as astrocytic 
differentiation of immature neoplastic glia. Using electron 
microscopy, Mandybur saw ENU-induced ependy-
momatous neoplasms not as true ependymal tumors but 
rather as primitive neuroepithelial neoplasms.20' In oligo-
dendrogliomas, the existence of transitional cells between 
oligodendrocytes and gemistcytic astrocytes,11' and GFAP-
positive neoplastic oligodendrocytes2.14.25.29.38) were re-
ported. Some authors reported transient GFAP expression 
by immature oligodendrocytes.1.3.14) The morphological 
variety and GFAP expression in inoculated tumors suggest 
that HITS glioma consist of immature neoplastic glia. 
 Raff et al. found a type of progenitor cell (0-2A progen-
itor cells) in the rat optic nerve capable of differentiating to
both oligodendrocytes and astrocytes depending on culture 
conditions.28' In humans, oligodendrogliomas may originate 
from 0-2A progenitor cells .4) In our laboratory, the anti-
genic expression of GD3, a marker for immature g lia in 
0-2A lineage"") was found in ENU-induced gliomas in 
vivo.36' Although, HITS glioma cells in cell culture and 
inoculated sites showed loss of the GD3 ganglioside ex-
pression, HITS glioma cells had the ability to form the 
tumor histopathologically mimicking the primary glioma. 
Therefore, loss of the antigenic expression of GD3 ganglio-
side in cultured cells and inoculated tumor cells may be due 
to the change of environment or dedifferentiation of the 
cells. The subpopulation of HITS glioma that expressed 
GFAP may belong to cells of 0-2A lineage, although 
oligodendrocytic differentiation of HITS glioma has been 
proven neither in vivo nor in vitro in the present study 
despite the oligodendrocytic morphological characteristics 
in vitro. MBP and GC are expressed by mature oligoden-
drocytes,27.35) and the possibility of the mixture of various 
differential stages of glial cells in HITS glioma is not 
denied. In this respect, cloning of HITS glioma and other 
antibodies specific for immature oligodendrocytes is neces-
sary for further investigation. 
  IGF-I, which is distributed throughout the central ner-
vous system,"' regulates the proliferation and differen-
tiation of glia.10.22'23) Specific receptors for IGF-I were also 
found in neoplastic glia.' 15.24' The present study suggested 
that IGF-I at physiological concentrations played a role in 
the proliferation of HITS glioma as well as neonatal glia in 
vitro. IGF-I induced the cell proliferation or differentiation 
of astrocytes in neonatal glial cultures, and not only the 
proportion but also the total number of GFAP positive cells 
was increased in the present study. However, GFAP was 
not detected in HITS glioma. Thus the expression of GFAP 
by HITS glioma in inoculated sites is probably mediated by 
other growth factors, for example, interleukins, fibroblast 
glowth factor etc. The importance of the extracellular 
matrix in the development of gliomas was also noted." 
Further examination using other culture conditions that 
mimic in vivo environments is necessary to elucidate the 
glial cell differentiation in vitro. 
  The studies on the role of growth factors on ontogenesis 
in the fetal brain, and the mechanisms of proliferation of 
tumor cells by growth factors in vitro may clarify the 
differentiation of normal glial lineage and neoplastic glia. 
HITS glioma is a unique cell line that differentiates to 
astrocytic cells under certain conditions. This cell line 
might serve as a way to promote understanding of the 
proliferation and differentiation of neoplastic glia, although 
the mechanism of astrocytic differentiation remains to be 
elucidated.
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